ProQuest Investments III, L.P. insider trades: Agile Therapeutics (AGRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where ProQuest Investments III, L.P. reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 27, 2016 | AGRX | ↑ Buy | 393,700 | $6.35 | $2.5M | Indirect | Jan 29, 2016 (2d) |
| Jan 23, 2015 | AGRX | ↑ Buy | 811,966 | $5.85 | $4.8M | Indirect | Jan 23, 2015 (0d) |
| May 29, 2014 | AGRX | ↑ Buy | 1,120,833 | $6.00 | $6.7M | Indirect | Jun 2, 2014 (4d) |
| Mar 31, 2010 | NVDL | ↑ Buy | 4,848,485 | $0.17 | $800K | See | Apr 1, 2010 (1d) |
| Sep 19, 2007 | CADX | ↓ Sell | 74,300 | $13.90 | $1.0M | Direct | Sep 19, 2007 (0d) |
| Sep 19, 2007 | CADX | ↓ Sell | 36,900 | $14.07 | $519K | Direct | Sep 19, 2007 (0d) |
| Sep 14, 2007 | CADX | ↓ Sell | 3,000 | $13.56 | $41K | Direct | Sep 14, 2007 (0d) |
| Sep 11, 2007 | CADX | ↓ Sell | 11,600 | $13.53 | $157K | Direct | Sep 12, 2007 (1d) |
| Sep 4, 2007 | CADX | ↓ Sell | 27,200 | $14.26 | $388K | Direct | Sep 4, 2007 (0d) |
| Aug 31, 2007 | CADX | ↓ Sell | 57,400 | $14.47 | $830K | Direct | Sep 4, 2007 (4d) |
| Aug 30, 2007 | CADX | ↓ Sell | 4,300 | $14.10 | $61K | Direct | Aug 31, 2007 (1d) |
| Aug 29, 2007 | CADX | ↓ Sell | 11,322 | $14.04 | $159K | Direct | Aug 30, 2007 (1d) |
| Aug 27, 2007 | CADX | ↓ Sell | 14,074 | $14.21 | $200K | Direct | Aug 27, 2007 (0d) |
| Aug 22, 2007 | CADX | ↓ Sell | 600 | $14.50 | $9K | Direct | Aug 24, 2007 (2d) |
| Aug 21, 2007 | CADX | ↓ Sell | 4,509 | $14.54 | $66K | Direct | Aug 22, 2007 (1d) |
| Aug 20, 2007 | CADX | ↓ Sell | 5,525 | $14.67 | $81K | By ProQuest Management LLC | Aug 22, 2007 (2d) |
| Aug 17, 2007 | CADX | ↓ Sell | 7,600 | $14.86 | $113K | By ProQuest Management LLC | Aug 21, 2007 (4d) |
| Jan 5, 2007 | NVD | ↑ Buy | 763,449 | $1.45 | $1.1M | Direct | Jan 26, 2007 (21d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About ProQuest Investments III, L.P.'s insider trades
ProQuest Investments III, L.P. is a 10% owner of Agile Therapeutics (AGRX). Since Jan 5, 2007, it has reported 5 open-market purchases worth $15.9M and 13 sales worth $3.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (8 filings), conversions (3 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AGRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.